Hearken to this text

MMI’s Symani system for robotic-assisted microsurgeries has tiny devices operated by a surgeon utilizing OperaAir controllers. | Supply: MMI

Editor’s Notice: This text was syndicated from The Robotic Report’s sibling web site MassDevice.

MMI (included as Medical Microinstruments) at the moment introduced the Symani surgical robotics platform’s first scientific instances within the U.S.

The 2 robotic-assisted microsurgical procedures had been carried out at Penn Presbyterian Medical Middle’s Division of Orthopaedic Surgical procedure.

Pisa, Italy-based MMI gained FDA de novo classification for the Symani Surgical System in April. The system secured a CE mark in 2019 and has racked up practically 1,000 scientific instances within the EU as of final month.

The primary U.S. instances had been reconstructive extremity microsurgeries, MMI mentioned in a information launch.

“In a single case, the group carried out a ‘free bone switch’ process on a affected person who suffered a traumatic harm; the process concerned transferring a phase of bone and pores and skin from their leg to a broken bone of their forearm,” the corporate mentioned. “The surgical group revascularized the bone phase utilizing the microsurgical robotic to reconnect the tiny blood vessels and facilitate profitable switch.”

“The second case concerned a affected person in danger for a leg amputation as a result of an contaminated knee prosthesis with comfortable tissue deficiency,” MMI continued. “The group repaired the extreme knee wound with muscle and pores and skin from the affected person’s again and robotically reconnected the blood vessels to advertise revascularization.”

MMI CEO Mark Toland referred to as the primary U.S. instances “a paramount milestone within the world growth of the Symani Surgical System, and we’re honored to have been in a position to work with Penn Drugs, a premiere orthopedic surgical procedure division, to attain it.”

“At present marks the start of a brand new period in surgical innovation, as sufferers throughout the nation with situations that require complicated microsurgical methods, corresponding to extremity reconstruction, autologous breast reconstruction put up most cancers resection and lymphedema restore, will now have expanded entry to therapy choices,” he mentioned within the information launch.

MMI designed Symani’s tiny NanoWrist devices to assist entry and suture small, delicate anatomies together with veins, arteries, nerves and lymphatic vessels as small as 0.3mm in diameter. It gives movement scaling and tremor discount to permit exact micro-movements. The articulated wrist options seven levels of freedom that match the human wrist, tremor filtration and movement scaling.

MMI has raised greater than $200 million, together with a $110 million Sequence C spherical in February and a $75 million Sequence B spherical in 2022.